GlassScriptPhysician profile
Abby Kent
NPI 1043999543
$943.81
in general payments reported to CMS, 2019-2025
16 companies · $458 in 2025
The $458 reported for 2025 was more than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $18.92 · 2024: $467 · 2025: $458.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $944.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $943.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Almatica Pharma LLC | $182.28 | 2024-2025 | Loreev Xr |
| Abbvie INC. | $154.04 | 2024-2025 | |
| Vanda Pharmaceuticals INC. | $137.70 | 2024-2025 | Fanapt, Hetlioz |
| Otsuka America Pharmaceutical, INC. | $106.13 | 2024-2025 | Rexulti, Abilify Asimtufii, Abilify Maintena |
| Lundbeck LLC | $103.34 | 2024 | Rexulti |
| Alkermes, INC. | $51.12 | 2024-2025 | Lybalvi, Aristada |
| Supernus Pharmaceuticals, INC. | $31.49 | 2025 | Qelbree |
| Janssen Pharmaceuticals, INC | $29.13 | 2024-2025 | Spravato |
| Bausch Health US, LLC | $24.29 | 2025 | Aplenzin |
| Axsome Therapeutics, INC. | $20.80 | 2024 | Auvelity |
| Neurocrine Biosciences, INC. | $20.59 | 2025 | |
| Harmony Biosciences LLC | $18.92 | 2023 | Wakix |
| Abiomed | $18.73 | 2024 | Impella |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $18.48 | 2024 | Caplyta |
| Takeda Pharmaceuticals U.S.A., INC. | $13.63 | 2024 | Trintellix |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neos Therapeutics, LP | $13.14 | 2024 | Adzenys Xr-Odt |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Abby Kent listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.